Morandini, Francesco
Rechsteiner, Cheyenne
Perez, Kevin
Praz, Viviane
Lopez Garcia, Guillermo
Hinte, Laura C.
von Meyenn, Ferdinand
Ocampo, Alejandro http://orcid.org/0000-0002-3731-3647
Funding for this research was provided by:
Novartis Stiftung für Medizinisch-Biologische Forschung
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
University of Lausanne
Article History
Received: 15 July 2023
Accepted: 14 October 2023
First Online: 4 November 2023
Declarations
:
: The study was approved by the internal review board of the Interregional Blood Transfusion SRC. Subjects provided written informed consent.
: Not applicable.
: K.P. and A.O. are co-founders and shareholders of EPITERNA SA (non-financial interests). A.O. is co-founder of Longevity Consultancy Group (non-financial interests). The rest of the authors have declared no financial or commercial conflict of interest.